ZMC(SH:600216) Xin Lang Cai Jing·2025-08-26 01:29Group 1 - Zhejiang Pharmaceutical (600216.SH) released its semi-annual report for 2025, showing that as of August 25, 2025, 12 institutional investors held a total of 460 million shares, accounting for 47.89% of the total share capital [1] - The top ten institutional investors collectively held 47.88% of the shares, with a 2.93 percentage point increase compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, Southern CSI 1000 ETF, increased its holdings by 0.12% compared to the previous period [2] - One fund, Innovation Medicine, decreased its holdings by 0.22% compared to the previous quarter [2] - Two new public funds were disclosed this period, including Southern Fengrui Quantitative Stock Selection Mixed A and Southern Fengyuan Quantitative Stock Selection Mixed A [2] - Sixteen public funds were not disclosed this period, including several funds focused on CSI 1000 index enhancement strategies [2]